About the Authors
- Livio Azzoni
-
Affiliation The Wistar Institute, Philadelphia, Pennsylvania, United States of America
- Russell Barbour
-
Affiliation Biostatistics Department, Yale School of Public Health, New Haven, Connecticut, United States of America
- Emmanouil Papasavvas
-
Affiliation The Wistar Institute, Philadelphia, Pennsylvania, United States of America
- Deborah K. Glencross
-
Affiliation Department of Molecular Medicine and Hematology, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa
- Wendy S. Stevens
-
Affiliation Department of Molecular Medicine and Hematology, University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa
- Mark F. Cotton
-
Affiliation Children’s Infectious Diseases Clinical Research Unit, Department of Paediatrics and Child Health, Stellenbosch University, Cape Town, South Africa
- Avy Violari
-
Affiliation Perinatal HIV Research Unit, University of the Witwatersrand, Johannesburg, South Africa
- Luis J. Montaner
-
* E-mail: Montaner@wistar.org
Affiliation The Wistar Institute, Philadelphia, Pennsylvania, United States of America
Competing Interests
GlaxoSmithKline plc (www.gsk.com) partially funded the CHER study by providing antiretroviral medications free of charge. No other compensation was provided from GlaxoSmithKline or any other commercial funders to the authors. This funding does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: LA RB EP MFC AV MFC LJM. Performed the experiments: LA EP DKG WSS MFC AV. Analyzed the data: LA RB MFC AV LJM. Contributed reagents/materials/analysis tools: EP DKG WSS MFC AV. Wrote the paper: LA RB EP DKG WSS MFC AV LJM. Clinical effort: AV MFC. Clinical laboratory tests: DKG WSS.